1. Home
  2. ADCT vs CGTL Comparison

ADCT vs CGTL Comparison

Compare ADCT & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • CGTL
  • Stock Information
  • Founded
  • ADCT 2011
  • CGTL 2016
  • Country
  • ADCT Switzerland
  • CGTL Hong Kong
  • Employees
  • ADCT N/A
  • CGTL N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • CGTL
  • Sector
  • ADCT Health Care
  • CGTL
  • Exchange
  • ADCT Nasdaq
  • CGTL NYSE
  • Market Cap
  • ADCT 127.9M
  • CGTL 128.2M
  • IPO Year
  • ADCT 2020
  • CGTL 2024
  • Fundamental
  • Price
  • ADCT $1.28
  • CGTL $0.89
  • Analyst Decision
  • ADCT Strong Buy
  • CGTL
  • Analyst Count
  • ADCT 5
  • CGTL 0
  • Target Price
  • ADCT $7.75
  • CGTL N/A
  • AVG Volume (30 Days)
  • ADCT 235.3K
  • CGTL 640.0K
  • Earning Date
  • ADCT 05-14-2025
  • CGTL 05-23-2025
  • Dividend Yield
  • ADCT N/A
  • CGTL N/A
  • EPS Growth
  • ADCT N/A
  • CGTL 35.72
  • EPS
  • ADCT N/A
  • CGTL 0.21
  • Revenue
  • ADCT $70,837,000.00
  • CGTL $35,611,761.00
  • Revenue This Year
  • ADCT $6.82
  • CGTL N/A
  • Revenue Next Year
  • ADCT $18.56
  • CGTL N/A
  • P/E Ratio
  • ADCT N/A
  • CGTL $3.95
  • Revenue Growth
  • ADCT 1.84
  • CGTL N/A
  • 52 Week Low
  • ADCT $1.05
  • CGTL $0.82
  • 52 Week High
  • ADCT $4.83
  • CGTL $10.59
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 43.00
  • CGTL N/A
  • Support Level
  • ADCT $1.23
  • CGTL N/A
  • Resistance Level
  • ADCT $1.49
  • CGTL N/A
  • Average True Range (ATR)
  • ADCT 0.08
  • CGTL 0.00
  • MACD
  • ADCT 0.00
  • CGTL 0.00
  • Stochastic Oscillator
  • ADCT 25.00
  • CGTL 0.00

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED

Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.

Share on Social Networks: